CD8A and neoplasm: While we did not perform repeat biopsies after cryotherapy to evaluate this possibility, a recent study of eight metastatic NSCLC patients by Desilets et al. found significant upregulation of tumor-infiltrating CD8 T cells in cases where a clinical benefit from immunotherapy with pembrolizumab was observed [27].